← All organizations
Highest phase reached
Phase 4
First clinical trial
May 1, 2004Last known activity
Sep 1, 2022
Timeline
1990s
- Jul 1, 1999
Government of Scotland— Founded
Drugs by trial phase (29 distinct, 18 trials)
Phase 4 (9 own, 0 via acquisition)
Phase 3 (4 own, 0 via acquisition)
Phase 2 (2 own, 0 via acquisition)
Indications
Studied for
- Asthma
- Atherosclerosis
- Carotid Artery Diseases
- Coronary Artery Disease
- Depression
- Depressive Disorder
- Diabetes, Gestational
- Diabetes Mellitus
- Femoral Neck Fractures
- Hypertension
- Hypertension, Pulmonary
- Lung Diseases
- Lung Diseases, Obstructive
- Nasal Polyps
- Poisoning
- Pulmonary Disease, Chronic Obstructive
- Respiratory Hypersensitivity
Recent trials (18)
- NCT05419583CollaboratorN/ASep 1, 2022
- NCT03659955CollaboratorN/ANov 7, 2017
- NCT02384174CollaboratorN/AMay 1, 2015
- NCT02080377CollaboratorPhase 3Jul 1, 2014
- NCT01544634CollaboratorPhase 2Mar 1, 2012
- NCT01306760CollaboratorPhase 4Mar 1, 2011
- NCT01226212CollaboratorN/ANov 1, 2010
- NCT01197469CollaboratorPhase 2Sep 1, 2010
- NCT01050270CollaboratorPhase 4Sep 1, 2010
- NCT01074853CollaboratorPhase 2May 1, 2010
- NCT00926666CollaboratorPhase 4Oct 1, 2009
- NCT00944112CollaboratorN/AAug 1, 2009
- NCT00901563CollaboratorN/AMar 1, 2009
- NCT00723307CollaboratorPhase 4Feb 1, 2009
- NCT00417404CollaboratorPhase 4Jan 31, 2007
Details
- Founded
- Edinburgh, GB Jul 1, 1999
- Last known activity
- Sep 1, 2022